GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, whether they utilize weight loss drugs or not,” IBX said in a statement.

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.

Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an anti-obesity drug to shed pounds. Why it matters: Musk's post highlighted just how mainstream weight-loss drugs like Ozempic and Wegovy have become in recent years as public figures openly admit to using them,